Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02938442
Title Vaccination of Triple Negative Breast Cancer Patients
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Arkansas
Indications

triple-receptor negative breast cancer

Therapies

Montanide ISA 51 + P10s-PADRE

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Highlands Oncology Group Fayetteville Arkansas 72703 United States Details
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field